Yes. The following templates can be used when citing material from RxVigilance.
The following templates can be used to cite elements of RxVigilance:
For RxVigilance in general:
RxVigilance version August 2024 [Software]. Repentigny (Quebec): Vigilance Santé Inc. [accessed 2024 Aug 2].
For a particular section of RxVigilance:
Product Monograph: Atorvastatin (Product Monographs). In: RxVigilance Release Aug 2024 [Software]. Repentigny: Vigilance Santé Inc. [cited 2024 Aug 2].
Comparison Table: Drugs Used in the Treatment of Hypertension (Comparison Tables). In: RxVigilance Release Aug 2024 [Software]. Repentigny: Vigilance Santé Inc. [accessed August 2, 2024].
Compound: Amlodipine 1 mg/mL oral suspension (Magistral). In: RxVigilance Release Aug 2024 [Software]. Repentigny: Vigilance Santé Inc. [cited 2024 Aug 2].
In compliance with copyright, the information quoted must not represent a substantial part of the software. Please also note that Vigilance Santé declines all responsibility for errors, omissions, losses or damages resulting from or related to the use (or misuse) of the information, or the conclusions contained or inferred from the information contained in the tool.